Differential bidirectional transfer of indinavir in the isolated perfused human placenta.
The protease inhibitor (PI) indinavir may be used in the management of human immunodeficiency virus (HIV) infection during pregnancy. Poor maternal-to-fetal transfer of indinavir has been reported previously, but the mechanisms of transfer remain unknown. The bidirectional transfer of indinavir was assessed in dually perfused, isolated human placentae. Term placentae (n = 5) were obtained from non-HIV-infected pregnant women. To investigate transport mechanisms, the steady-state transfer of indinavir was compared to those of antipyrine (a marker of passive diffusion) and [(3)H]vinblastine (a marker of P-glycoprotein [P-gp] transport) in the maternal-to-fetal and fetal-to-maternal directions in each placenta. Indinavir and antipyrine perfusate concentrations were determined by using reverse-phase, high-performance liquid chromatography; [(3)H]vinblastine concentrations were measured by liquid scintillation. The antipyrine transfer clearance in each direction did not differ (P = 0.76), a finding consistent with passive diffusion. However, the maternal-to-fetal transfer clearance of vinblastine, normalized to that of antipyrine (clearance index) (0.31 +/- 0.05), was significantly lower than the fetal-to-maternal clearance index of vinblastine (0.67 +/- 0.17; P = 0.017), suggesting the involvement of placental P-gp. Similarly, the maternal-to-fetal clearance index of indinavir (0.39 +/- 0.09) was significantly lower than its fetal-to-maternal clearance index (0.97 +/- 0.12; P < 0.001). These results represent the first evidence for differential transfer of a xenobiotic in the intact human placenta. The use of transport modulators to increase the maternal-to-fetal transfer of PIs as a possible strategy to reduce mother-to-child transmission of HIV warrants investigation.
Sudhakaran
Sreeja
S
Facility for Anti-Infective Drug Development and Innovation, Monash University, 381 Royal Parade, Parkville, 3052, Melbourne, Australia.
Ghabrial
Hany
H
Nation
Roger L
RL
Kong
David C M
DC
Gude
Neil M
NM
Angus
Peter W
PW
Rayner
Craig R
CR
D001692:Biological Transport; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics*; D006801:Humans; D019469:Indinavir / Q000493:pharmacokinetics*; D008431:Maternal-Fetal Exchange; D010477:Perfusion; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy
D017320:HIV Protease Inhibitors; D019469:Indinavir
N Engl J Med. 1999 Aug 5;341(6):394-402
10432324
N Engl J Med. 2000 Oct 5;343(14):982-91
11018164
Am J Obstet Gynecol. 1972 Nov 15;114(6):822-8
4676572
Am J Physiol Cell Physiol. 2003 Sep;285(3):C584-91
12724138
AIDS. 2000 Jun 16;14(9):1287-9
10894301
Am J Obstet Gynecol. 2001 Jul;185(1):178-81
11483925
J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):484-94
11981365
Mol Pharmacol. 1999 Aug;56(2):383-9
10419558
Adv Drug Deliv Rev. 2003 Jan 21;55(1):125-32
12535577
Infect Dis Obstet Gynecol. 1998;6(6):244-6
9972485
Clin Pharmacokinet. 2003;42(1):59-98
12489979
Antiviral Res. 1998 Jul;39(1):1-23
9754946
Am J Obstet Gynecol. 1998 Sep;179(3 Pt 1):758-61
9757985
AIDS. 2000 Feb 18;14(3):237-42
10716499
Antimicrob Agents Chemother. 2004 Sep;48(9):3226-32
15328077
J Infect Dis. 2001 Feb 15;183(4):539-45
11170978
Eur J Pharmacol. 2000 Nov 10;408(1):1-10
11070177
AIDS. 2000 Oct 20;14(15):2293-7
11089617
Clin Pharmacokinet. 1995 Mar;28(3):235-69
7758253
Br J Clin Pharmacol. 2001 Apr;51(4):301-8
11318764
MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4
12489844
AIDS. 2002 Apr 12;16(6):889-93
11919490
Placenta. 1991 Nov-Dec;12(6):653-61
1805205
Antimicrob Agents Chemother. 1998 Dec;42(12):3157-62
9835508
Biochemistry. 1998 Mar 17;37(11):3594-601
9530286
N Engl J Med. 1995 Aug 3;333(5):298-302
7596375
J Pharmacol Exp Ther. 1987 Jun;241(3):1006-9
3598898
Adv Drug Deliv Rev. 1999 Jun 14;38(1):81-97
10837748
J Acquir Immune Defic Syndr. 2000 Dec 1;25(4):306-11
11114830
J Pharmacol Exp Ther. 1988 Sep;246(3):1093-7
3418511
Placenta. 1981 Apr-Jun;2(2):149-54
7232336
Ann Pharmacother. 2001 Nov;35(11):1391-5
11724090
J Clin Invest. 1999 Nov;104(10):1441-7
10562306
Clin Pharmacokinet. 1995 Feb;28(2):161-80
7736690
Pediatr Infect Dis J. 2002 Sep;21(9):835-8
12352805